CIK 0001512762
- Accelerated filer
- Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273615821
- Phone
- +1 650-649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes President and CEO gave up 17,867 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 6,297 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 6,404 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 5,916 shares (to pay taxes)
- 4/A Derivatives Options or other derivatives
- 3/A Insider 3/A
- 4/A Derivatives Options or other derivatives
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Chief Financial Officer acquired 740 shares (option exercise)
- 4 Open-market sale Chief Medical Officer sold 1,760 shares at $18.58 ($32,699)
- 4 Open-market sale Director sold 25,000 shares at $20.50 ($512,500)
- 4 Open-market sale Chief Medical Officer sold 1,760 shares at $19.02 ($33,480)
- 4 Open-market sale Chief Financial Officer sold 9,291 shares at $18.56 ($172,472)
- 4 Open-market sale Chief Medical Officer sold 1,760 shares at an average $15.01 ($26,415)
- 4 Open-market sale Chief Medical Officer sold 1,760 shares at $15.00 ($26,400)
- 4 Open-market sale Lanfear Dennis M sold 20,984 shares at $16.26 ($341,265)
- 4 Derivatives Options or other derivatives
Page 12 of 20 · 399 filings